Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Investigation of the relationship between maternal serum vasohibin-1, vasohibin-2, cardiotrophin -1 and endocan concentrations at the 11th and 14th weeks of gestation and adverse perinatal outcomes.
Eligibility Criteria
Inclusion Criteria: * Those who had the first-trimester screening test between 11 and 14 weeks of pregnancy and are in the low-risk group * Those with singleton pregnancy * Those who did not conceive pregnancy with assisted reproductive treatment methods * Those who do not have any pregestational diseases * Those who do not have any uterine anomalies Exclusion Criteria: * Smokers * Those who are in the high-risk group with the first trimester screening test * Those with multiple pregnancies * Those who conceive with assisted reproductive treatment methods * Those who had any disease before pregnancy * Those who have any uterine anomalies